Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 14/20 | 0.49 |
| ▸ | CPB1 | P15086 | 7/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.40 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17044394 | 1.00 | CPB2 (0.49) | CPB2CPB1ITGB3ITGA2B | |
| SCHEMBL22392864 | 1.00 | CPB2 (0.49) | CPB2CPB1ITGB3ITGA2B | |
| SCHEMBL636655 | 1.00 | CPB2 (0.49) | CPB2CPB1ITGB3ITGA2B | |
| SCHEMBL8896989 | 0.99 | CPB2 (0.48) | CPB2CPB1ITGB3ITGA2B | |
| SCHEMBL9110288 | 0.99 | CPB2 (0.48) | CPB2CPB1ITGB3ITGA2B | |
| SCHEMBL5663758 | 0.88 | CPB2 (0.50) | CPB2CPB1ITGB3ITGA2B | |
| SCHEMBL5964769 | 0.88 | CPB2 (0.48) | CPB2CPB1ITGB3ITGA2B | |
| SCHEMBL4393104 | 0.88 | HDAC6 (0.47) | CPB2CPB1 | |
| SCHEMBL5964147 | 0.88 | CPB2 (0.50) | CPB2CPB1ITGB3ITGA2B | |
| SCHEMBL11225379 | 0.87 | CPB2 (0.49) | CPB2CPB1ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119970545-A | Composite carnosine composition and preparation method thereof | 苏州富士莱医药股份有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119735552-A | Synthesis method of N-acetyl-L-carnosine | 甘肃瑞德林生物有限公司 | 2025-04-01 | — | — | CN | claimed |
| US-20230310461-A1 | Compositions and Methods for Treatment of Prediabetes | CROSS III WILLIAM H (US) | 2023-10-05 | — | — | US | claimed |
| US-11684623-B2 | Soluble melatonin tripartate adduct for the prevention and treatment of rare and severe eye sight-threatening conditions and neuro-ophthalmic disorders | WORPHMED SRL (IT) | 2023-06-27 | — | — | US | claimed |
| US-11612632-B2 | Compositions and methods for treatment of prediabetes | CROSS III WILLIAM H (US) | 2023-03-28 | — | — | US | claimed |
| CN-114295755-A | Marker for early diagnosis of gestational diabetes and application thereof | 华中科技大学 | 2022-04-08 | — | — | CN | claimed |
| CN-111480740-A | Preparation and application of high-nutrition nonpregnant sow feed | 叶平凡 | 2020-08-04 | — | — | CN | claimed |
| CN-111466491-A | Preparation of feed additive for nonpregnant sows | 叶平凡 | 2020-07-31 | — | — | CN | claimed |
| US-10406383-B2 | Apparatus for treatment of dermatological conditions | CAREWEAR CORP. (US) | 2019-09-10 | — | — | US | claimed |
| US-20180303896-A1 | Compositions and Methods for Treatment of Prediabetes | CROSS III WILLIAM H (US) | 2018-10-25 | — | — | US | claimed |
| EP-2431075-B1 | Apparatus for treatment of dermatological conditions | SONOVIA HOLDINGS LLC (US) | 2017-04-05 | — | — | EP | claimed |
| US-20140086855-A1 | COMBINED USE OF A CARNOSINASE INHIBITOR WITH L-CARNOSINE OR ITS RELATED SUBSTANCE AND A COMPOSITION CONTAINING THE SAME | INNOVATIVE VISION PRODUCTS, INC. (US) | 2014-03-27 | — | — | US | claimed |
| EP-2431075-A1 | Apparatus for treatment of dermatological conditions | Sonovia Limited (GB) | 2012-03-21 | — | — | EP | claimed |
| CN-101585813-B | Prepartion method of N-acetyl-L-carnosine | CHANGSHU FUSHILAI MEDICINE & CHEMICAL CO LTD | 2011-04-13 | — | — | CN | claimed |
| US-20100330170-A1 | Flavored Vegetarian Cellulose Capsule and Methods for Producing said Capsule | CAPSULINE, INC. (US) | 2010-12-30 | — | — | US | claimed |
| CN-101585813-A | Prepartion method of N-acetyl-L-carnosine | CHANGSHU FUSLAI PHARMACEUTICAL (CN) | 2009-11-25 | — | — | CN | claimed |
| US-20060222699-A1 | FLAVORED VEGETARIAN CELLULOSE CAPSULE AND METHODS FOR PRODUCING SAID CAPSULE. | CAPSULE, INC. | 2006-10-05 | — | — | US | claimed |
| US-20060116328-A1 | Combined use of carnosinase inhibitor with l-carnosines and composition | INNOVATIVE VISION PRODUCTS, INC. | 2006-06-01 | — | — | US | claimed |
| EP-1586332-A1 | COMBINED USE OF CARNOSINASE INHIBITOR WITH L-CARNOSINES AND COMPOSITION | Innovative Vision Products, Inc. (US) | 2005-10-19 | — | — | EP | claimed |
| US-4387232-A | Process for preparing N-acylcarnosine | AJINOMOTO COMPANY INCORPORATED (JP) | 1983-06-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11684623-B2 | Soluble melatonin tripartate adduct for the prevention and treatment of rare and severe eye sight-threatening conditions and neuro-ophthalmic disorders | HIF1A, HIF1AN, MTNR1A | CPB2 4315/4885CPB1 4244/4885ITGB3 2469/4885 |
| US-20060116328-A1 | Combined use of carnosinase inhibitor with l-carnosines and composition | LCT, ADH1C, PON1 | CPB2 550/4885CPB1 223/4885ITGB3 4835/4885 |
| US-11612632-B2 | Compositions and methods for treatment of prediabetes | GPX1, GPX4, GLS2 | CPB2 1213/4885CPB1 1596/4885ITGB3 1151/4885 |
| US-20140086855-A1 | COMBINED USE OF A CARNOSINASE INHIBITOR WITH L-CARNOSINE OR ITS RELATED SUBSTANCE AND A COMPOSITION CONTAINING THE SAME | LCT, CPA1, ADH1C | CPB2 379/4885CPB1 146/4885ITGB3 4842/4885 |
| US-20230310461-A1 | Compositions and Methods for Treatment of Prediabetes | GPX1, GPX4, NFE2L2 | CPB2 2518/4885CPB1 2815/4885ITGB3 532/4885 |
| US-20180303896-A1 | Compositions and Methods for Treatment of Prediabetes | GPX1, GPX4, GLS2 | CPB2 1213/4885CPB1 1596/4885ITGB3 1151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.